SVWAG
Sound View Wealth Advisors Group’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $641K | Buy |
5,100
+190
| +4% | +$23.9K | 0.05% | 240 |
|
|
2025
Q1 | $543K | Sell |
4,910
-26
| -0.5% | -$2.88K | 0.04% | 244 |
|
|
2024
Q4 | $674K | Buy |
4,936
+652
| +15% | +$89K | 0.05% | 228 |
|
|
2024
Q3 | $494K | Buy |
4,284
+823
| +24% | +$94.8K | 0.04% | 255 |
|
|
2024
Q2 | $476K | Sell |
3,461
-314
| -8% | -$43.2K | 0.05% | 241 |
|
|
2024
Q1 | $521K | Sell |
3,775
-407
| -10% | -$56.1K | 0.06% | 231 |
|
|
2023
Q4 | $551K | Sell |
4,182
-352
| -8% | -$46.4K | 0.06% | 222 |
|
|
2023
Q3 | $510K | Buy |
4,534
+515
| +13% | +$57.9K | 0.06% | 216 |
|
|
2023
Q2 | $379K | Buy |
4,019
+515
| +15% | +$48.6K | 0.05% | 258 |
|
|
2023
Q1 | $355K | Sell |
3,504
-678
| -16% | -$68.6K | 0.05% | 264 |
|
|
2022
Q4 | $551K | Buy |
4,182
+2,119
| +103% | +$279K | 0.06% | 222 |
|
|
2022
Q3 | $219K | Buy |
+2,063
| New | +$219K | 0.05% | 248 |
|